Sherbrooke Park Advisers LLC Pds Biotechnology Corp Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 14,026 shares of PDSB stock, worth $17,251. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,026
Previous 40,182
65.09%
Holding current value
$17,251
Previous $153 Million
85.11%
% of portfolio
0.01%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding PDSB
# of Institutions
59Shares Held
4.22MCall Options Held
170KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA1.51MShares$1.85 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$598,9690.0% of portfolio
-
Geode Capital Management, LLC Boston, MA417KShares$513,1760.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA247KShares$303,7810.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il220KShares$270,8640.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $35M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...